Anal fissure medical therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Overview
Most common cause of anal fissure is straining when constipated. For treatment of constipation, click here. Anal fissures in infants usually self-heal without anything more than frequently changing diapers and treating constipation if it is the cause. The topical therapy is the first line of treatment along with dietary and other conservative measures. Analgesia with lidocaine and vasodilators like nitroglycerin and nifedipine are chiefly used for the topical management. Botulinum toxin can be effective in 89% cases. It is reserved for the people who can’t undergo surgery for high risk of incontinence.
Medical Therapy
Medical Therapy
- For many years up until 1995, customary treatment included warm baths, topical anesthetics, stool bulking agents, mechanical anal stretching, and, sometimes, surgery. In 1995, doctors began using nitroglycerine cream (topical 1 percent isosorbide dinitrate) but found it less acceptable for long-term use due to patients developing a tolerance to the drug. In 1998, Italian researchers reported injecting botulinum toxin into the anal sphincter to promote healing by relieving anal spasm through relaxation of the muscle.
- Most common cause of anal fissure is straining when constipated. For treatment of constipation, click here.
Symptomatic
- Most anal fissures are shallow or superficial (less than a quarter of an inch or 0.64 cm deep). These fissures self-heal within a couple of weeks. Furthermore, the treatment used for hemorrhoid such as eating a high-fiber diet, using a stool softener, taking a painkiller and having a sitz bath can help.
- Preferred regimen, sitz bath: anus to be immersed in warm water for 10-15 minutes q8-12h for 4 weeks.[1][2][3][4][5]
Pediatric
- Anal fissures in infants usually self-heal without anything more than frequently changing diapers and treating constipation if it is the cause.
Chemical Sphincterotomy
- Painful deep chronic fissures, will not heal because of poor blood supply caused by sphincter spasm. Traditionally, surgical operations were required which are both painful and associated with various long-term complications, particularly incontinence in a small proportion of cases.
- Botulinum toxin injection, administered by colorectal surgeons, can also be used to relax the sphincter muscle and its use for this condition was first investigated in 1993.[6] Botulinum toxin can provide relief in 89% cases.[7] Combination of medical therapies may offer up to 98% cure rates.[8][3]
- Botulinum toxin is reserved for the people who can’t undergo surgery due to high risk for incontinence.[9][10]
- Preferred regimen (1): Botulinum toxin type A (Botox) 10 Units (0.2 ml of 50 U/mL) intrasphincteric q30 days for 16 months.[11]
Topical medical therapy
The topical therapy is the first line of treatment along with dietary and other conservative measures.[12] Analgesia and vasodilators are chiefly used for the topical management.[4][13][14][15][16][17]
Topical analgesic
- Preferred regimen: Lidocaine gel 2-5% to be applied locally as needed.
Topical vasodilators
- Preferred regimen (1): Nitroglycerin 0.2 or 0.4% ointment to be applied rectally q12h for 8 weeks.[18][19][20]
- Preferred regimen (2): Nifedipine 0.2-0.3% ointment to be applied topically q6-12h.[21][22]
- Alternative regimen (1): Diltiazem 2% rectal gel q8h for 8 weeks.[23]
- Alternative regimen (2): Bethanechol 0.1% rectal gel q8h for 8 weeks.
References
References
- β Wald A, Bharucha AE, Cosman BC, Whitehead WE (2014). “ACG clinical guideline: management of benign anorectal disorders”. Am. J. Gastroenterol. 109 (8): 1141β57, (Quiz) 1058. doi:10.1038/ajg.2014.190. PMIDΒ 25022811.
- β Gupta P (2006). “Randomized, controlled study comparing sitz-bath and no-sitz-bath treatments in patients with acute anal fissures”. ANZ J Surg. 76 (8): 718β21. doi:10.1111/j.1445-2197.2006.03838.x. PMIDΒ 16916391.
- β 3.0 3.1 Nelson RL, Thomas K, Morgan J, Jones A (2012). “Non surgical therapy for anal fissure”. Cochrane Database Syst Rev (2): CD003431. doi:10.1002/14651858.CD003431.pub3. PMIDΒ 22336789.
- β 4.0 4.1 Jensen SL (1986). “Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran”. Br Med J (Clin Res Ed). 292 (6529): 1167β9. PMCΒ 1340178. PMIDΒ 3011180.
- β Nelson R (2006). “Non surgical therapy for anal fissure”. Cochrane database of systematic reviews (Online) (4): CD003431. PMIDΒ 17054170.
- β Jost W, Schimrigk K (1993). “Use of botulinum toxin in anal fissure”. Dis Colon Rectum. 36 (10): 974. PMID 8404394.
- β Radwan MM, Ramdan K, Abu-Azab I, Abu-Zidan FM (2007). “Botulinum toxin treatment for anal fissure”. Afr Health Sci. 7 (1): 14β7. doi:10.5555/afhs.2007.7.1.14. PMCΒ 2366122. PMIDΒ 17604520.
- β Tranqui P, Trottier D, Victor C, Freeman J (2006). “Nonsurgical treatment of chronic anal fissure: nitroglycerin and dilatation versus nifedipine and botulinum toxin” (PDF). Canadian journal of surgery. Journal canadien de chirurgie. 49 (1): 41β5. PMIDΒ 16524142.
- β Jost WH (1997). “One hundred cases of anal fissure treated with botulin toxin: early and long-term results”. Dis. Colon Rectum. 40 (9): 1029β32. PMIDΒ 9293930.
- β Jost WH, Schrank B (1999). “Repeat botulin toxin injections in anal fissure: in patients with relapse and after insufficient effect of first treatment”. Dig. Dis. Sci. 44 (8): 1588β9. PMIDΒ 10492136.
- β Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A (1998). “A comparison of botulinum toxin and saline for the treatment of chronic anal fissure”. N. Engl. J. Med. 338 (4): 217β20. doi:10.1056/NEJM199801223380402. PMIDΒ 9435326.
- β Haq Z, Rahman M, Chowdhury R, Baten M, Khatun M (2005). “Chemical sphincterotomy–first line of treatment for chronic anal fissure”. Mymensingh Med J. 14 (1): 88β90. PMID 15695964.
- β Davies D, Bailey J (2017). “Diagnosis and Management of Anorectal Disorders in the Primary Care Setting”. Prim. Care. 44 (4): 709β720. doi:10.1016/j.pop.2017.07.012. PMIDΒ 29132530.
- β Schlichtemeier S, Engel A (2016). “Anal fissure”. Aust Prescr. 39 (1): 14β7. doi:10.18773/austprescr.2016.007. PMCΒ 4816871. PMIDΒ 27041801.
- β Carapeti EA, Kamm MA, Phillips RK (2000). “Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects”. Dis. Colon Rectum. 43 (10): 1359β62. PMIDΒ 11052511.
- β Knight JS, Birks M, Farouk R (2001). “Topical diltiazem ointment in the treatment of chronic anal fissure”. Br J Surg. 88 (4): 553β6. doi:10.1046/j.1365-2168.2001.01736.x. PMIDΒ 11298624.
- β Jonas M, Speake W, Scholefield JH (2002). “Diltiazem heals glyceryl trinitrate-resistant chronic anal fissures: a prospective study”. Dis. Colon Rectum. 45 (8): 1091β5. PMIDΒ 12195195.
- β Loder P, Kamm M, Nicholls R, Phillips R (1994). “‘Reversible chemical sphincterotomy’ by local application of glyceryl trinitrate”. Br J Surg. 81 (9): 1386β9. PMID 7953427.
- β Watson S, Kamm M, Nicholls R, Phillips R (1996). “Topical glyceryl trinitrate in the treatment of chronic anal fissure”. Br J Surg. 83 (6): 771β5. PMID 8696736.
- β Simpson J, Lund J, Thompson R, Kapila L, Scholefield J (2003). “The use of glyceryl trinitrate (GTN) in the treatment of chronic anal fissure in children”. Med Sci Monit. 9 (10): PI123β6. PMID 14523338.
- β Antropoli C, Perrotti P, Rubino M, Martino A, De Stefano G, Migliore G, Antropoli M, Piazza P (1999). “Nifedipine for local use in conservative treatment of anal fissures: preliminary results of a multicenter study”. Dis Colon Rectum. 42 (8): 1011β5. PMID 10458123.
- β Katsinelos P, Kountouras J, Paroutoglou G, Beltsis A, Chatzimavroudis G, Zavos C, Katsinelos T, Papaziogas B (2006). “Aggressive treatment of acute anal fissure with 0.5% nifedipine ointment prevents its evolution to chronicity”. World J Gastroenterol. 12 (38): 6203β6. PMID 17036396.
- β Carapeti E, Kamm M, Phillips R (2000). “Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects”. Dis. Colon Rectum. 43 (10): 1359β62. PMIDΒ 11052511.
ββ Template:WH Template:WS
Looking for the patient version?
Β© 2026 MyEClinic β IFTM Institut fΓΌr Telematik in der Medizin GmbH
